Trials | Descriptive Psychometrics | Correlations | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
 | Mean | (SD) | Min | Max | α | SEM | FSI Total | FSI Severity | FSI Interference | FSI-3 |
MBSR (N = 106) | ||||||||||
 FSI Total | 5.06 | (1.58) | 0.54 | 8.00 | 0.93 | 0.43 | – |  |  |  |
 FSI Severity | 5.25 | (1.46) | 1.00 | 8.50 | 0.81 | 0.63 | 0.81** | – |  |  |
 FSI-Interference | 4.79 | (1.94) | 0.00 | 8.71 | 0.91 | 0.59 | 0.97** | 0.64** | – |  |
 FSI-3 | 5.47 | (1.83) | 0.67 | 9.33 | 0.81 | 0.79 | 0.93** | 0.75** | 0.90** | – |
 SF-36 Vitality | 32.41 | (15.90) | 0.00 | 75.00 | 0.74 | 8.05 | − 0.57** | − 0.44** | − 0.53** | − 0.50** |
BEAT (N = 222) | ||||||||||
 FSI Total | 3.85 | (1.86) | 0.92 | 8.92 | 0.95 | 0.40 | – |  |  |  |
 FSI Severity | 4.58 | (1.91) | 1.00 | 9.25 | 0.89 | 0.63 | 0.90** | – |  |  |
 FSI-Interference | 3.38 | (2.03) | 1.00 | 9.29 | 0.93 | 0.52 | 0.96** | 0.76** | – |  |
 FSI-3 | 4.13 | (2.19) | 1.00 | 10.00 | 0.87 | 0.78 | 0.97** | 0.87** | 0.94** | – |
 SF-36 Vitality | 51.23 | (20.22) | 0.00 | 87.50 | 0.84 | 8.08 | − 0.79** | − 0.72** | − 0.75** | − 0.78** |